DOI: 10.1039/d6ra04017a ISSN: 2046-2069
Dual targeting of VEGFR-2 and FAK kinases by novel benzimidazole-oxadiazole hybrids: a potential approach in cancer therapy
Heba T. Abdel-Mohsen, Mohamed A. Omar, Amira M. Nageeb, Ahmed S. Abdelsamie, Ahmed M. El KerdawyIn the current study a new class of benzimidazole-oxadiazole hybrids was investigated as dual VEGFR-2 and FAK kinases inhibitors targeting cancer.